Advertisement

House Committees Launch Investigation Into Alzheimer's Drug08:07
Download

Play

Two House committees are now investigating the drug aducanumab, which was approved by the Food and Drug Administration to treat Alzheimer's disease.

Here & Now's Peter O'Dowd talks with Damian Garde, a reporter at STAT.

This segment aired on July 1, 2021.

Advertisement

Advertisement